These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 36230903)

  • 1. Advances in Biomarkers and Endogenous Regulation of Breast Cancer Stem Cells.
    Chen W; Zhang L; Liu S; Chen C
    Cells; 2022 Sep; 11(19):. PubMed ID: 36230903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer stem cell: the roles and therapeutic implications.
    Yang F; Xu J; Tang L; Guan X
    Cell Mol Life Sci; 2017 Mar; 74(6):951-966. PubMed ID: 27530548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel molecular regulators of breast cancer stem cell plasticity and heterogeneity.
    Zhang R; Tu J; Liu S
    Semin Cancer Biol; 2022 Jul; 82():11-25. PubMed ID: 33737107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer stem cell in breast cancer therapeutic resistance.
    Bai X; Ni J; Beretov J; Graham P; Li Y
    Cancer Treat Rev; 2018 Sep; 69():152-163. PubMed ID: 30029203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel lncRNA ROPM-mediated lipid metabolism governs breast cancer stem cell properties.
    Liu S; Sun Y; Hou Y; Yang L; Wan X; Qin Y; Liu Y; Wang R; Zhu P; Teng Y; Liu M
    J Hematol Oncol; 2021 Oct; 14(1):178. PubMed ID: 34715882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer stem cells, heterogeneity, targeting therapies and therapeutic implications.
    Zeng X; Liu C; Yao J; Wan H; Wan G; Li Y; Chen N
    Pharmacol Res; 2021 Jan; 163():105320. PubMed ID: 33271295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cancer stem cells: current advances and clinical implications.
    Luo M; Clouthier SG; Deol Y; Liu S; Nagrath S; Azizi E; Wicha MS
    Methods Mol Biol; 2015; 1293():1-49. PubMed ID: 26040679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation of breast cancer stem cells by knockdown of CD44: promising differentiation therapy.
    Pham PV; Phan NL; Nguyen NT; Truong NH; Duong TT; Le DV; Truong KD; Phan NK
    J Transl Med; 2011 Dec; 9():209. PubMed ID: 22152097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Therapeutics Against Breast Cancer Stem Cells by Targeting Surface Markers and Signaling Pathways.
    Das PK; Rakib MA; Khanam JA; Pillai S; Islam F
    Curr Stem Cell Res Ther; 2019; 14(8):669-682. PubMed ID: 31808385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. JAK/STAT3-Regulated Fatty Acid β-Oxidation Is Critical for Breast Cancer Stem Cell Self-Renewal and Chemoresistance.
    Wang T; Fahrmann JF; Lee H; Li YJ; Tripathi SC; Yue C; Zhang C; Lifshitz V; Song J; Yuan Y; Somlo G; Jandial R; Ann D; Hanash S; Jove R; Yu H
    Cell Metab; 2018 Jan; 27(1):136-150.e5. PubMed ID: 29249690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical and Clinical Trials of New Treatment Strategies Targeting Cancer Stem Cells in Subtypes of Breast Cancer.
    Landeros N; Castillo I; Pérez-Castro R
    Cells; 2023 Feb; 12(5):. PubMed ID: 36899854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting Breast Cancer Stem Cells.
    Zhang L; Chen W; Liu S; Chen C
    Int J Biol Sci; 2023; 19(2):552-570. PubMed ID: 36632469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel Lnc408 maintains breast cancer stem cell stemness by recruiting SP3 to suppress CBY1 transcription and increasing nuclear β-catenin levels.
    Wen S; Qin Y; Wang R; Yang L; Zeng H; Zhu P; Li Q; Qiu Y; Chen S; Liu Y; Hou Y; Tang X; Liu M; Tu G
    Cell Death Dis; 2021 May; 12(5):437. PubMed ID: 33934099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RAC1B function is essential for breast cancer stem cell maintenance and chemoresistance of breast tumor cells.
    Chen F; Gurler SB; Novo D; Selli C; Alferez DG; Eroglu S; Pavlou K; Zhang J; Sims AH; Humphreys NE; Adamson A; Campbell A; Sansom OJ; Tournier C; Clarke RB; Brennan K; Streuli CH; Ucar A
    Oncogene; 2023 Feb; 42(9):679-692. PubMed ID: 36599922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancer stem cells as novel biomarkers.
    Ray SK; Mukherjee S
    Clin Chim Acta; 2024 Apr; 557():117855. PubMed ID: 38453050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNAs, a subpopulation of regulators, are involved in breast cancer progression through regulating breast cancer stem cells.
    Fan X; Chen W; Fu Z; Zeng L; Yin Y; Yuan H
    Oncol Lett; 2017 Nov; 14(5):5069-5076. PubMed ID: 29142594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNAs, a Promising Target for Breast Cancer Stem Cells.
    Das PK; Siddika MA; Asha SY; Aktar S; Rakib MA; Khanam JA; Pillai S; Islam F
    Mol Diagn Ther; 2020 Feb; 24(1):69-83. PubMed ID: 31758333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects and mechanisms of SLC34A2 on maintaining stem cell-like phenotypes in CD147
    Lv Y; Wang T; Fan J; Zhang Z; Zhang J; Xu C; Li Y; Zhao G; He C; Meng H; Yang H; Wang Z; Liu J; Chen J; Wang L
    Tumour Biol; 2017 Apr; 39(4):1010428317695927. PubMed ID: 28381172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The BET degrader ZBC260 suppresses stemness and tumorigenesis and promotes differentiation in triple-negative breast cancer by disrupting inflammatory signaling.
    Sharma D; Hager CG; Shang L; Tran L; Zhu Y; Ma A; Magnuson B; Lesko MW; Wicha MS; Burness ML
    Breast Cancer Res; 2023 Nov; 25(1):144. PubMed ID: 37968653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. β1,4-Galactosyltransferase V Modulates Breast Cancer Stem Cells through Wnt/β-catenin Signaling Pathway.
    Tang W; Li M; Qi X; Li J
    Cancer Res Treat; 2020 Oct; 52(4):1084-1102. PubMed ID: 32599982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.